US FDA Offers More Advice On Mid-Trial Changes For Pandemic-Impacted Studies

 
• By Sue Sutter
Shetland Sheepdog in agility slalom. Sized to fit for cover image on popular social media site.
High-level regulatory guidance is allowing sponsors to take an agile approach to mitigating trial impacts. • Source: Shutterstock

More from Clinical Trials

More from R&D